KRS Capital Management »

Regeneron Pharmaceuticals shares owned by KRS Capital Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by KRS Capital Management from 13F filings

Historical chart of KRS Capital Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by KRS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by KRS Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $318k 330 962.49
2023-12-31 $290k 330 878.29
2023-09-30 $272k 330 822.96
2023-06-30 $248k 345 718.54
2023-03-31 $284k 345 821.67
2022-12-31 $256k 355 721.49
2022-09-30 $216k 315 685.71
2022-03-31 $220k 315 698.41
2021-12-31 $198k 315 628.57